Looking to cure Type 1 diabetes

Beyond Biotech - the podcast from Labiotech

Contenido proporcionado por Labiotech. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente Labiotech o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.

16d ago 23:40

MP3•Episodio en casa

Diamyd Medical develops precision medicine therapies for the prevention and treatment of Type 1 diabetes and LADA (latent autoimmune diabetes in adults).

Diamyd is an antigen-specific immunomodulatory therapeutic for the preservation of endogenous insulin production. It has been granted Orphan Drug Designation in the U.S. as well as Fast Track Designation.

DIAGNODE-3, a confirmatory phase 3 trial, uses injections into a superficial lymph node can to optimize the treatment response.

This week on the podcast we have a conversation about treatments of type 1 diabetes, including the company’s development of Diamyd. Our guest is Anders Essen-Möller, founder and chairman of Diamyd Medical.

00:51-19:16: Diamyd Medical’s approach to Type 1 diabetes
19:16-21:03: Other approaches to tackling Type 1 diabetes
21:03-22:08: Keeping costs of Type 1 diabetes treatment low
22:08-22:53: Can Type 1 diabetes be cured?
Interested in being a sponsor of an episode of our podcast? Discover how you can get involved here!

Stay updated by subscribing to our newsletter

Capíttulos

1. Looking to cure Type 1 diabetes (00:00:00)

2. Diamyd Medical’s approach to tackling Type 1 diabetes (00:00:51)

3. Other approaches to tackling Type 1 diabetes (00:19:16)

4. eeping costs of Type 1 diabetes treatment low  (00:21:03)

5. Can Type 1 diabetes be cured? (00:22:08)

103 episodios

#News #Tech News #Labiotech